SVWAG
JAZZ icon

Sound View Wealth Advisors Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sound View Wealth Advisors Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
7,757
-1,141
-13% -$250K 0.12% 143
2026
Q1 		$1.68M Buy
8,898
+102
+1% +$17.8K 0.11% 140
2025
Q4 		$1.5M Sell
8,796
-501
-5% -$76.8K 0.1% 151
2025
Q3 		$1.23M Buy
9,297
+164
+2% +$19.7K 0.08% 178
2025
Q2 		$969K Buy
9,133
+708
+8% +$76.9K 0.07% 190
2025
Q1 		$1.05M Buy
8,425
+110
+1% +$14.3K 0.09% 168
2024
Q4 		$1.02M Buy
8,315
+206
+3% +$24.3K 0.08% 172
2024
Q3 		$903K Buy
8,109
+1,422
+21% +$156K 0.07% 191
2024
Q2 		$714K Buy
6,687
+2,100
+46% +$231K 0.07% 195
2024
Q1 		$552K Buy
4,587
+167
+4% +$20.5K 0.06% 227
2023
Q4 		$544K Buy
4,420
+702
+19% +$87.6K 0.06% 225
2023
Q3 		$481K Buy
3,718
+648
+21% +$86.3K 0.06% 224
2023
Q2 		$381K Buy
+3,070
New +$413K 0.05% 257
2023
Q1 		– Sell
-4,420
Closed -$544K – 389
2022
Q4 		$544K Buy
+4,420
New +$648K 0.06% 225

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Sound View Wealth Advisors Group's JAZZ Position: Q2 2026 in Review

Sound View Wealth Advisors Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q2 2026, selling an estimated $250K and leaving 7,757 shares worth $1.87M. The position accounts for 0.12% of the portfolio, ranked #143.

Sound View Wealth Advisors Group first reported a position in JAZZ in Q4 2022 and has held it in 14 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Sound View Wealth Advisors Group held 7,757 shares of Jazz Pharmaceuticals worth $1.87M as of Q2 2026.
  • Sound View Wealth Advisors Group sold 1,141 Jazz Pharmaceuticals shares in Q2 2026, an estimated $250K.
  • Jazz Pharmaceuticals made up 0.12% of Sound View Wealth Advisors Group's portfolio in Q2 2026, its #143 holding.
  • Sound View Wealth Advisors Group first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q2 2026, filed 11 Aug 2026.